Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA

被引:155
作者
Lentacker, Ine [1 ]
De Geest, Bruno G. [1 ]
Vandenbroucke, Roosmarijn E. [1 ]
Peeters, Liesbeth [1 ]
Demeester, Joseph [1 ]
De Smedt, Stefaan C. [1 ]
Sanders, Niek N. [1 ]
机构
[1] Univ Ghent, Fac Pharm, Lab Gen Biochem & Phys Pharm, B-9000 Ghent, Belgium
关键词
D O I
10.1021/la0603828
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Ultrasound in combination with microbubbles has recently been considered by gene delivery scientists to be an interesting approach to enhance gene transfer into cells. Its low toxicity and simplicity to apply in vivo without major complications make this technology (sonoporation) especially attractive. Sonoporation of DNA has been evaluated in vivo by the injection of free plasmid DNA (pDNA) together with microbubbles (as used in diagnostic imaging) in the bloodstream. However, the in vivo gene-transfer efficiency in these experiments remained rather low. Both the enzymatic degradation of the injected pDNA as well as the low pDNA concentration in the neighborhood of sonoporated cell membranes may explain this low efficiency. Therefore, we developed polymer-coated microbubbles that can bind and protect the pDNA. Coating albumin-shelled microbubbles with poly(allylamine hydrochloride) (PAH) makes the surface charge of the microbubbles positive without drastically affecting the size distribution of the microbubbles, thereby not affecting the ultrasound responsiveness and injectability. The cationic coating allowed both to bind up to 0.1 pg of DNA per microbubble as well as to protect the bound DNA against nucleases. Finally, the PAH coating significantly increased the lifetime of the microbubbles (half-life approximate to 7 h), making them more convenient for in vivo applications because more microbubbles are expected to reach the target organ. Binding and nuclease protection of DNA by polymer-coated diagnostic microbubbles has, to our knowledge, never been demonstrated. We conclude that these LbL-coated microbubbles might be significant in the further development of ultrasound-mediated gene delivery.
引用
收藏
页码:7273 / 7278
页数:6
相关论文
共 31 条
[1]   Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction [J].
Bekeredjian, R ;
Chen, SY ;
Grayburn, PA ;
Shohet, RV .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2005, 31 (05) :687-691
[2]   Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction [J].
Chen, SY ;
Shohet, RV ;
Bekeredjian, R ;
Frenkel, P ;
Grayburn, PA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) :301-308
[3]   Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles [J].
Christiansen, JP ;
French, BA ;
Klibanov, AL ;
Kaul, S ;
Lindner, JR .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2003, 29 (12) :1759-1767
[4]   Self-rupturing microcapsules [J].
De Geest, BG ;
Déjugnat, C ;
Sukhorukov, GB ;
Braeckmans, K ;
De Smedt, SC ;
Demeester, J .
ADVANCED MATERIALS, 2005, 17 (19) :2357-+
[5]   Fuzzy nanoassemblies: Toward layered polymeric multicomposites [J].
Decher, G .
SCIENCE, 1997, 277 (5330) :1232-1237
[6]   Therapeutic ultrasound optimization for gene delivery: A key factor achieving nuclear DNA localization [J].
Duvshani-Eshet, M ;
Machluf, M .
JOURNAL OF CONTROLLED RELEASE, 2005, 108 (2-3) :513-528
[7]   DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro [J].
Frenkel, PA ;
Chen, SY ;
Thai, T ;
Shohet, RV ;
Grayburn, PA .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2002, 28 (06) :817-822
[8]   Current and future contrast agents [J].
Grayburn, PA .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2002, 19 (03) :259-265
[9]   Dissolution of multicomponent microbubbles in the bloodstream: 2. Experiment [J].
Kabalnov, A ;
Bradley, J ;
Flaim, S ;
Klein, D ;
Pelura, T ;
Peters, B ;
Otto, S ;
Reynolds, J ;
Schutt, E ;
Weers, J .
ULTRASOUND IN MEDICINE AND BIOLOGY, 1998, 24 (05) :751-760
[10]   Diagnostic use of serum deoxyribonuclease I activity as a novel early-phase marker in acute myocardial infarction [J].
Kawai, Y ;
Yoshida, M ;
Arakawa, K ;
Kumamoto, T ;
Morikawa, N ;
Masamura, K ;
Tada, H ;
Ito, S ;
Hoshizaki, H ;
Oshima, S ;
Taniguchi, K ;
Terasawa, H ;
Miyamori, I ;
Kishi, K ;
Yasuda, T .
CIRCULATION, 2004, 109 (20) :2398-2400